Skip to main content
logo
Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
6.87
-0.10 (-1.43%)
At close: Mar 4, 2026, 4:00 PM EST
6.87
0.00 (0.00%)
After-hours: Mar 4, 2026, 5:38 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2024FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Jan '24 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Precision Medicine
621.93M508.51M329.21M-
-
Precision Medicine Growth
22.30%54.47%--
-
Therapeutics
9.27M6.23M3.50M-
-
Therapeutics Growth
48.94%78.09%--
-
Manufacturing Solutions
245.11M1.82M277.00K-
-
Manufacturing Solutions Growth
13389.54%555.96%--
-
Inter-Segment Elimination
-72.51M---
-
Commercial
---106.28M
-
Product Development
---2.53M
-
Pharmaceuticals
----
4.02M
Pharmaceuticals Growth
----
64.26%
Total
803.79M516.55M332.98M108.81M
4.02M
Total Growth
55.61%55.13%206.01%-
64.26%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2024FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Jan '24 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
China
9.83M382.00K863.00K2.28M
-
China Growth
2474.35%-55.74%-62.13%-
-
United States
784.91M502.76M324.47M101.95M
-
United States Growth
56.12%54.95%218.25%-
-
Other Countries
9.06M13.41M7.64M2.70M
-
Other Countries Growth
-32.47%75.49%182.54%-
-
Australia
---101.27K
4.02M
Australia Growth
----
64.26%
Belgium
---383.33K
-
United Kingdom
---1.39M
-
Total
803.79M516.55M332.98M108.81M
4.02M
Total Growth
55.61%55.13%206.01%-
64.26%
Source: S&P Global Market Intelligence.